Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03613545

Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Efficacy and Safety of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Guangzhou First People's Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. FMT has a higher cure rate than standard antibiotic treatment for recurrent Clostridium difficile infections,and shows promising results in Inflammatory bowel disease(IBD).However, few studies have evaluated whether FMT is effective to treat Irritable bowel syndrome(IBS).The investigators propose to determine the efficiency and safety of FMT in patients with Irritable bowel syndrome.

Detailed description

The present clinical trial aims to re-establish a gut functionality state of intestinal flora through FMT as a therapy for Irritable bowel syndrome(IBS). We established a standard microbiota isolation from donated fresh stool in lab. Then the microbiota is transplanted to the whole colon through a tube. Patients from Guangzhou First People's Hospital in this study will be assigned to receive FMT at least two times according to associated guidelines and follow-up for at least six months. Questionnaires will be used to assess participants at study start and at study completion.

Conditions

Interventions

TypeNameDescription
PROCEDUREfecal microbiota transplantation200 mL of prepared fecal microbiota suspension from heathy donors' fresh feces was injected into the colon
PROCEDUREInfusion of shamInfusion of sham
DRUGprobiotics, antibiotics or antidepressantsDrugs such as probiotics, antibiotics, antidepressants

Timeline

Start date
2018-08-10
Primary completion
2028-12-31
Completion
2030-12-31
First posted
2018-08-03
Last updated
2021-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03613545. Inclusion in this directory is not an endorsement.